Bond S A, Han A M, Wootton S A, Kohler J A
Department of Human Nutrition, University of Southampton.
Arch Dis Child. 1992 Feb;67(2):229-32. doi: 10.1136/adc.67.2.229.
Energy intakes and basal metabolic rates were determined in 26 children receiving chemotherapy in remission from acute lymphoblastic leukaemia or solid tumours and 26 healthy controls matched for age and sex. Body weight and height on the two groups were comparable, although one patient was stunted (height for age) and three others wasted (weight for height). Energy intake in the patients at 7705 kJ/day (1842 kcal) and controls at 7773 kJ/day (1866 kcal)) and basal metabolic rate (BMR) in the patients at 4873 kJ/day (1172 kcal) and controls 4987 kJ/day (1196 kcal) for the two groups were not significantly different. Although the energy intake:BMR ratio for both groups was 1.59, the range of values for the patient group was large (0.96-2.73) and appeared to be greater than that observed in the control group (1.23-2.46). These results demonstrated that during this period of chemotherapy there was no evidence of raised energy expenditure at rest or reduced energy intake in the patient group. No indication of undernutrition in the patients as a group was evident, although some individuals might require further clinical nutritional assessment.
对26名急性淋巴细胞白血病或实体瘤化疗缓解期儿童及26名年龄和性别匹配的健康对照者测定了能量摄入和基础代谢率。两组的体重和身高具有可比性,不过有1例患者身材矮小(年龄别身高),另有3例消瘦(身高别体重)。患者组的能量摄入量为7705千焦/天(1842千卡),对照组为7773千焦/天(1866千卡);患者组的基础代谢率(BMR)为4873千焦/天(1172千卡),对照组为4987千焦/天(1196千卡),两组之间无显著差异。虽然两组的能量摄入:基础代谢率比值均为1.59,但患者组的数值范围较大(0.96 - 2.73),似乎高于对照组(1.23 - 2.46)。这些结果表明,在化疗期间,患者组没有证据显示静息能量消耗增加或能量摄入减少。尽管部分个体可能需要进一步的临床营养评估,但总体而言患者中没有营养不良的迹象。